Jyoti S Mayadev MD
Associate Professor, Radiation Oncology, University of California San Diego School of Medicine
Join to View Full Profile
200 W Arbor DrSan Diego, CA 92103
Phone+1 800-926-8273
Dr. Mayadev is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonResidency, Radiation Oncology, 2005 - 2009
Providence Health & Services - Oregon/St Vincent Hospital and Medical CenterInternship, Internal Medicine, 2004 - 2005
Case Western Reserve University School of MedicineClass of 2004
Certifications & Licensure
OR State Medical License 2004 - Present
CA State Medical License 2009 - 2027
WA State Medical License 2007 - 2017
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Start of enrollment: 2012 Nov 01
- Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer Start of enrollment: 2012 Oct 01
- Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery Start of enrollment: 2013 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial.Charles A Leath 3rd, Wei Deng, Loren K Mell, Debra L Richardson, Joan L Walker
Gynecologic Oncology. 2025-04-01 - Modeling dosimetric benefits from daily adaptive RT for gynecological cancer patients with and without knowledge-based dose prediction.Rupesh Ghimire, Lance Moore, Daniela Branco, Dominique L Rash, Jyoti S Mayadev
Journal of Applied Clinical Medical Physics. 2025-03-01 - 2 citationsNeoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial.Jyoti Mayadev, Dmitriy Zamarin, Wei Deng, Heather A Lankes, Giulio Pesci
Nature Communications. 2025-01-09
Press Mentions
No Doubt: Ultrasensitive ctDNA Blood Test Sets Bar for MRD Cervical CancerJune 10th, 2025- Could Liquid Biopsy Guide Treatment in Cervical Cancer?June 5th, 2025
- Personalis’ NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCOJune 3rd, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
